537 related articles for article (PubMed ID: 33466753)
1. Ubiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control.
Peris-Moreno D; Cussonneau L; Combaret L; Polge C; Taillandier D
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466753
[TBL] [Abstract][Full Text] [Related]
2. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury.
Aniort J; Polge C; Claustre A; Combaret L; Béchet D; Attaix D; Heng AE; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():505-516. PubMed ID: 27102410
[TBL] [Abstract][Full Text] [Related]
4. A critical discussion on the relationship between E3 ubiquitin ligases, protein degradation, and skeletal muscle wasting: it's not that simple.
Hughes DC; Goodman CA; Baehr LM; Gregorevic P; Bodine SC
Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1567-C1582. PubMed ID: 37955121
[TBL] [Abstract][Full Text] [Related]
5. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
6. Edward F. Adolph Distinguished Lecture. Skeletal muscle atrophy: Multiple pathways leading to a common outcome.
Bodine SC
J Appl Physiol (1985); 2020 Aug; 129(2):272-282. PubMed ID: 32644910
[TBL] [Abstract][Full Text] [Related]
7. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
8. Molecular signaling pathways regulating muscle proteolysis during atrophy.
Franch HA; Price SR
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):271-5. PubMed ID: 15809529
[TBL] [Abstract][Full Text] [Related]
9. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
10. MuRF1/TRIM63, Master Regulator of Muscle Mass.
Peris-Moreno D; Taillandier D; Polge C
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933049
[TBL] [Abstract][Full Text] [Related]
11. Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes.
Eo H; Reed CH; Valentine RJ
Biomed Pharmacother; 2020 Aug; 128():110238. PubMed ID: 32450522
[TBL] [Abstract][Full Text] [Related]
12. UBE2D2 is not involved in MuRF1-dependent muscle wasting during hindlimb suspension.
Polge C; Koulmann N; Claustre A; Jarzaguet M; Serrurier B; Combaret L; Béchet D; Bigard X; Attaix D; Taillandier D
Int J Biochem Cell Biol; 2016 Oct; 79():488-493. PubMed ID: 27378730
[TBL] [Abstract][Full Text] [Related]
13. Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation.
Haberecht-Müller S; Krüger E; Fielitz J
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572540
[TBL] [Abstract][Full Text] [Related]
14. Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy.
Eddins MJ; Marblestone JG; Suresh Kumar KG; Leach CA; Sterner DE; Mattern MR; Nicholson B
Cell Biochem Biophys; 2011 Jun; 60(1-2):113-8. PubMed ID: 21448668
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-Proteasome Pathway and Muscle Atrophy.
Khalil R
Adv Exp Med Biol; 2018; 1088():235-248. PubMed ID: 30390254
[TBL] [Abstract][Full Text] [Related]
16. Identification of the MuRF1 Skeletal Muscle Ubiquitylome Through Quantitative Proteomics.
Baehr LM; Hughes DC; Lynch SA; Van Haver D; Maia TM; Marshall AG; Radoshevich L; Impens F; Waddell DS; Bodine SC
Function (Oxf); 2021; 2(4):zqab029. PubMed ID: 34179788
[TBL] [Abstract][Full Text] [Related]
17. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.
Sacheck JM; Ohtsuka A; McLary SC; Goldberg AL
Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E591-601. PubMed ID: 15100091
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
[TBL] [Abstract][Full Text] [Related]
19. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle.
Edström E; Altun M; Hägglund M; Ulfhake B
J Gerontol A Biol Sci Med Sci; 2006 Jul; 61(7):663-74. PubMed ID: 16870627
[TBL] [Abstract][Full Text] [Related]
20. Proinflammatory cytokines and skeletal muscle.
Späte U; Schulze PC
Curr Opin Clin Nutr Metab Care; 2004 May; 7(3):265-9. PubMed ID: 15075917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]